Xia W - Search Results

1

IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.

Chan LC, Li CW, Xia W, Hsu JM, Lee HH, Cha JH, Wang HL, Yang WH, Yen EY, Chang WC, Zha Z, Lim SO, Lai YJ, Liu C, Liu J, Dong Q, Yang Y, Sun L, Wei Y, Nie L, Hsu JL, Li H, Ye Q, Hassan MM, Amin HM, Kaseb AO, Lin X, Wang SC, Hung MC. Chan LC, et al. Among authors: xia w. J Clin Invest. 2019 Jul 15;129(8):3324-3338. doi: 10.1172/JCI126022. eCollection 2019 Jul 15. J Clin Invest. 2019. PMID: 31305264 Free PMC article.

2

Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.

Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC. Yu D, et al. Among authors: xia w. Oncogene. 1995 Oct 5;11(7):1383-8. Oncogene. 1995. PMID: 7478560

3

HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model.

Zhang Y, Yu D, Xia W, Hung MC. Zhang Y, et al. Among authors: xia w. Oncogene. 1995 May 18;10(10):1947-54. Oncogene. 1995. PMID: 7761095

4

Mutant SV40 large T antigen as a therapeutic agent for HER-2/neu-overexpressing ovarian cancer.

Xing X, Matin A, Yu D, Xia W, Sorgi F, Huang L, Hung MC. Xing X, et al. Among authors: xia w. Cancer Gene Ther. 1996 May-Jun;3(3):168-74. Cancer Gene Ther. 1996. PMID: 8725881

5

Inhibition of intratracheal lung cancer development by systemic delivery of E1A.

Chang JY, Xia W, Shao R, Hung MC. Chang JY, et al. Among authors: xia w. Oncogene. 1996 Oct 3;13(7):1405-12. Oncogene. 1996. PMID: 8875978

6

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.

Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC. Chang JY, et al. Among authors: xia w. Oncogene. 1997 Feb 6;14(5):561-8. doi: 10.1038/sj.onc.1200861. Oncogene. 1997. PMID: 9053854

7

Safety studies of the intraperitoneal injection of E1A--liposome complex in mice.

Xing X, Liu V, Xia W, Stephens LC, Huang L, Lopez-Berestein G, Hung MC. Xing X, et al. Among authors: xia w. Gene Ther. 1997 Mar;4(3):238-43. doi: 10.1038/sj.gt.3300376. Gene Ther. 1997. PMID: 9135737

8

Cross-reactivity of C219 anti-p170(mdr-1) antibody with p185(c-erbB2) in breast cancer cells: cautions on evaluating p170(mdr-1).

Liu B, Sun D, Xia W, Hung MC, Yu D. Liu B, et al. Among authors: xia w. J Natl Cancer Inst. 1997 Oct 15;89(20):1524-9. doi: 10.1093/jnci/89.20.1524. J Natl Cancer Inst. 1997. PMID: 9337349

9

Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo.

Deng J, Xia W, Hung MC. Deng J, et al. Among authors: xia w. Oncogene. 1998 Oct 29;17(17):2167-75. doi: 10.1038/sj.onc.1202148. Oncogene. 1998. PMID: 9811448

10

Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.

Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC. Xia W, et al. Clin Cancer Res. 1997 Jan;3(1):3-9. Clin Cancer Res. 1997. PMID: 9815530

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,016 results

Search Page